CELL C HOLDINGS LIMITED - Cancellation of S604172 - Change statement on AFS disclosures, availability of annual report and notice of annual general meeting
What this filing means
Cell C has reissued its audited annual financial statements for the year ended 31 May 2026 to correct the presentation of two note reconciliations — Note 14 (Trade and other receivables) and Note 17 (Advances to customers) — with updated sign conventions and line classifications. The filing explicitly confirms that the corrections affect disclosure only: no balance sheet, income statement, cash flow, EPS, HEPS or closing balances change. The Updated AFS are now the definitive record, and the Company has also enhanced its disclosure review controls going forward. This is a presentation correction with no economic substance, and the AGM notice of 19 November 2026 is the ordinary next step in the corporate calendar.
Cell C is saying it found a clerical error in how two notes to its accounts were laid out — the numbers themselves are the same, just presented differently. Think of it like correcting a typo on a bank statement: the actual balance does not change. The Company also tightened its internal review process, which is a governance improvement, but it does not alter what shareholders own or what the business earned. There is no new financial information here.
Bear case
- Missing evidence: the Updated AFS restate the note reconciliations but this announcement does not reproduce the full Updated AFS figures, so the reader must access the document directly to verify the corrected presentations.
AI-generated summary by SENS-AI, based on the original JSE SENS filing.
SENS-AI conclusion
This is a disclosure correction, not a financial event. Cell C has restated the sign conventions and classifications in two note reconciliations (Note 14 and Note 17) while confirming in writing that every material financial line — balance sheet, income statement, cash flow, EPS, HEPS and closing balances — is unchanged. The board has also confirmed enhanced disclosure controls, which is a genuine governance step but one that operates forward, not backward. So what: the business results are unchanged, and the market still has the full Updated AFS as the definitive record of Cell C's financial position — this filing adds nothing new on either the bull or bear side.
The 19 November 2026 AGM is where any substantive shareholder business will be tested, not in these corrected note disclosures.
Evidence from the filing
No new financial information — all material lines unchanged.
“These disclosure updates do not change either: the separate annual financial statements (Company AFS) the amounts recognised in the Group's Statement of Financial Position, Statement of Profit or Loss and other Comprehensive Income, Statement of Cash Flows or Statement of Changes in Equity; the closing balances of the affected notes; or earnings per share (basic and diluted) or headline earnings per share.”
Closing balance unchanged confirms no financial statement impact.
“The closing allowance remains unchanged at (R252.116) million”
Closing balance unchanged confirms no financial statement impact.
“The closing expected credit loss allowance remains (R510.523) million, and the carrying amount of advances to customers remain unchanged”
More on Cell C Holdings Limited
Related filings
More from CCD
- CELL C HOLDINGS LIMITED - Change statement on AFS disclosures, availability of annual report and notice of annual general meeting
- CELL C HOLDINGS LIMITED - Change statement on AFS disclosures, availability of annual report and notice of annual general meeting
- CELL C HOLDINGS LIMITED - Dealing in securities by a director
- CELL C HOLDINGS LIMITED - Dealing in securities by a director
- CELL C HOLDINGS LIMITED - Audited financial results for the year ended 31 May 2026